Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02681614 · ClinicalTrials.gov registry record · NA
Pilot Study Evaluating the Role of Histopathology Correlation in Treatment Planning
A NA study, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT02681614 is a NA study that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 5 participants.
The verdict
NCT02681614, a NA study, has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
This clinical research study tests the Uronav system. Patients with prostate cancer will be asked to take part in this study. Uronav system is an investigational device that is used on this study to help place markers in the patient. These are called fiducial markers and they are placed in the patient to help plan radiation treatment. Radiation therapy treatment will be planned by the treating physician and will not be experimental or part of this research study. This study will also test the similarities and differences of biopsy tissue structures and the findings from the intraprostatic MRI (internally guided MRI).
Interventions
- DEVICE Magnetic resonance imaging
- DEVICE Uronav guided biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2016-07-21 |
| Est. Completion | 2018-02-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02681614
The ClinicalTrials.gov registry entry for NCT02681614 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Magnetic resonance imaging is the first listed.
NCT02681614 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02681614 about?
NCT02681614 is a clinical study titled "Pilot Study Evaluating the Role of Histopathology Correlation in Treatment Planning". This clinical research study tests the Uronav system. Patients with prostate cancer will be asked to take part in this study. Uronav system is an investigational device that is used on this study to help place markers in the patient. These are called fiducial markers and they are placed in the pati...
What is the current status of trial NCT02681614?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2016-07-21. Estimated completion is 2018-02-11.
What interventions are being tested in trial NCT02681614?
The interventions under investigation include: Magnetic resonance imaging (DEVICE), Uronav guided biopsy (DEVICE).
Who is sponsoring clinical trial NCT02681614?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.